The Rivkin Center works tirelessly towards a world where women live longer, healthier lives because cancers are prevented, caught early, or cured.
Investing in cutting-edge research to prevent, detect, and treat ovarian cancer, a deadly and underfunded disease.
Over $14 Million
224 Research Grants Funded
Largest Applicant Pool
11.5x Return on Investment
Our current funding rate is 8%, meaning we are leaving important science on the table. We want to see funding rates increase to 15% in two years.
Educated over 31k women
40% of programming
Low Income, Minority, LGBTQ+, Ashkenazi Jewish Heritage
Represented at all Pac-12 schools
95% of attendants
People assessed their risk for ovarian and breast cancer on Rivkin website in 2020. That’s up from 792 in 2018.
Fostering an ever-growing community of survivors, patients, researchers, clinicians, and advocates.
32% increase in attendees
(over 250 attendees)
2,000 SummeRun Participants
For more details and information on the Rivkin Center’s work in 2019: